The expression of ICAM-1 and CD18 integrins is increased in patients with RA, and TNFα induces expression of both ICAM-1 and CD18 as well as activation of CD18 integrins to an active, ligand-binding conformation [[37], [38], [39]]. The gene discussed is ITGB2; the disease is rheumatoid arthritis.